There is now overwhelming evidence that all
babies should be offered screening for heart defects at birth, according to a
major new study published online in The Lancet.
Heart
defects are the most common type of birth defects in
the UK. Although newborns often show no visible signs of the condition, if not
treated promptly it can be fatal.
The
research, led by a Queen Mary, University of London academic with a colleague
from the University of Birmingham, shows that a non-invasive test called pulse oximetry offers
an accurate and cost effective screening tool.
Pulse
oximetry measures the amount of oxygen circulating in the blood stream using a
sensor placed on a thin part of the body such as the fingertip, or earlobe, or
in the case of the newborn, the foot.
Heart defects in newborns, also know as congenital heart
disease, affect almost one percent of babies born in the UK
each year – around 5,000 in total.
Previous
research indicates that around half of these babies will be undiagnosed when
mother and baby are discharged from hospital. Surgery can successfully treat
the most serious cases but it is most effective when the defect is picked up
early.
The new
research, which brings together the results of 13 separate studies, is the
largest of its kind and includes data on close to 230,000 babies.
It
shows that pulse oximetry can successfully detect birth defects and that it is
most accurate when used to screen babies around 24 hours after birth.
Researchers say it could easily be combined with existing newborn screening
which checks for other, less common types of birth defects
Results
showed that using pulse oximetry picked up more than three quarters (76.5 per
cent) of heart defects.
They
also showed that the test hardly ever wrongly diagnosed healthy babies as
having a heart defect. This means that there is very little unnecessary stress
for parents given an incorrect diagnosis of a heart defect.
Currently
some heart defects are picked up by ultrasound scan carried out when a woman is
around 20 weeks pregnant or by physical examination of the newborn baby, but
many cases are missed.
The
research was led by Dr Shakila Thangaratinam, a Clinical Senior Lecturer at
Queen Mary, University of London. She said: "Heart defects in newborn
babies are thankfully rare but their potential impact is devastating.
"This
study is really important because by including such large numbers of babies, we
can show that pulse oximetry is effective at picking up defects, without
misdiagnosing healthy babies. Previous research also indicates that it is
cost-effective.
"This
study is the best evidence yet that using pulse oximetry to screen for heart
defects should be included in the newborn health checks."
No comments:
Post a Comment